arrow_back Back to App

Limiting HIV/AIDS Funding for District of Columbia

This bill proposes to cap federal funding for HIV/AIDS testing and treatment in the District of Columbia for fiscal year 2024. This means the available amount for these purposes cannot exceed $3 million. This could impact the availability of HIV/AIDS related health services for residents of the District of Columbia.
Key points
Federal funds for HIV/AIDS testing and treatment in D.C. for 2024 will be capped at $3 million.
This may affect the scope and availability of prevention and treatment programs for individuals impacted by HIV/AIDS in D.C.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2104
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for District of Columbia, Federal Payment for Testing and Treatment of HIV/AIDS for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2104.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • Federal funds for HIV/AIDS testing and treatment in D.C. for 2024 will be capped at $3 million.
  • This may affect the scope and availability of prevention and treatment programs for individuals impacted by HIV/AIDS in D.C.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Oversight and Accountability.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health